Grey Fox Wealth Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 1965362 ROCKLAND, DE

Position in ABBV

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$610,730

+$124,640 QoQ

Shares Held

2,427

+8.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.83%

of 13F equity value

Holder Rank

#2,992

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Grey Fox Wealth Advisors, LLC holds $4,922,184 across 4 Drug Manufacturers - General names. ABBV ranks #3 (12.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	10,053	$2,553,160
2	LLY	ELI LILLY & Co	1,189	$1,426,122
3	ABBV	AbbVie Inc. This page	2,427	$610,730
4	MRK	Merck & Co., Inc.	2,585	$332,172

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$610,730	2,427	+8.6%	Shares	Sole	2026-07-17
2026-03-31	$486,090	2,235	-13.9%	Shares	Sole	2026-04-21
2025-12-31	$592,931	2,595	-2.6%	Shares	Sole	2026-02-12
2025-09-30	$617,054	2,665	-1.0%	Shares	Sole	2025-10-29
2025-06-30	$499,874	2,693	-1.6%	Shares	Sole	2025-08-06
2025-03-31	$573,665	2,738	+1.1%	Shares	Sole	2025-05-02
2024-12-31	$481,033	2,707	+0.2%	Shares	Sole	2025-02-11
2024-09-30	$533,393	2,701	-3.9%	Shares	Sole	2024-10-22
2024-06-30	$481,971	2,810	+12.0%	Shares	Sole	2024-07-30
2024-03-31	$457,071	2,510	+0.2%	Shares	Sole	2024-04-11
2023-12-31	$388,044	2,504	+0.3%	Shares	Sole	2024-01-18
2023-09-30	$372,202	2,497	+3.2%	Shares	Sole	2023-10-24
2023-06-30	$326,046	2,420	-20.3%	Shares	Sole	2023-08-03
2023-03-31	$484,166	3,038	+1.1%	Shares	Sole	2023-05-09
2022-12-31	$485,476	3,004	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.